Compare DigitalOcean Holdings Inc (DOCN) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DigitalOcean Holdings Inc vs TransMedics Group Inc — how do they compare? DigitalOcean Holdings Inc trades at $130.15 (market cap $14.57B), while TransMedics Group Inc trades at $77.31 (market cap $2.74B). The key difference: DigitalOcean Holdings Inc is far larger — about 5.3× TransMedics Group Inc's market cap, and DigitalOcean Holdings Inc is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DigitalOcean Holdings Inc for 43 Days and TransMedics Group Inc for 24 Days on average.
| DOCN | TMDX | |
|---|---|---|
Market Cap | $14.57B | $2.74B |
Volume | 2,261,786 | 949,331 |
Sector | Technology | Health |
52-Week High | $181.29 | $150.42 |
52-Week Low | $37.30 | $61.99 |
Typical Hold Time | 43 Days | 24 Days |
Enterprise Value | $15.33B | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DigitalOcean trades at $127.28, down 2.89% today, with strong fundamentals including 29% revenue growth and consistent earnings beats. The company shows robust profitability with 57.22% gross margins and 23.27% net income margin, though valuation metrics remain elevated with P/E of 56.32. Recent AI-focused product launches and $725 million equipment financing facility support growth initiatives. Technical indicators show mixed signals with bullish oscillators but bearish moving averages, trading near key support at $126.
Outlook remains positive with analyst consensus target of $172.73 (35.7% upside) and 68% buy ratings. Key opportunities include AI-driven revenue growth and expanding cloud market share, while risks include high valuation, negative shareholder equity, and competitive pressure from larger cloud providers. The stock offers growth potential but requires careful monitoring of execution and market conditions.
TransMedics Group (TMDX) trades at $80.69, down 0.47% on the day, amid a bearish technical signal and mixed earnings performance. The company reported strong revenue growth to $605.49M in 2025 with a net income margin of 22.69%, but recent quarters have seen earnings misses. Analyst sentiment remains positive with a consensus price target of $99.75 and a 69% buy rating, though news flow includes investigations into fiduciary duties.
The outlook balances robust fundamentals against near-term headwinds. Upside potential exists from the high analyst target and strong profitability metrics like a 36.28% ROE, but risks include earnings volatility, margin pressure, and ongoing legal scrutiny. The stock's current valuation at a P/E of 20.47 offers a reasonable entry if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DigitalOcean Holdings Inc
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.
Read more on DOCN →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
